Not Signed In -
Irinotecan |
Camptosar |
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Irinotecan Systematic (IUPAC) name (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy- 3,14-dioxo1H-pyrano[3’,4’:6,7]-indolizino[1,2-b]quinolin- 9-yl-[1,4’bipiperidine]-1’-carboxylate Identifiers CAS number 100286-90-6 ATC code L01XX19 PubChem 3750 DrugBank APRD00579 Chemical data Formula C33H38N4O6 Mol. weight 586.678 g/mol 677.185 g/mol (hydrochloride) Pharmacokinetic data Bioavailability NA Metabolism Hepatic glucuronidation Half life 6 to 12 ...
Wikipedia - [full article]
Irinotecan Clinical Trials
- Irinotecan in Treating Patients With Newly Diagnosed or Relapsed Non- Hodgkin's Lymphoma or Leukemia
ClinicalTrials.gov Identifier: NCT00005626 - Active, not recruiting
Lymphoma; Leukemia
- Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00053144 - Active, not recruiting
Myeloid Leukemia
- Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00005036 - Active, not recruiting
Colon Cancer; Rectal Cancer
- Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00040807 - Active, not recruiting
Head and Neck Cancer
- Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors
ClinicalTrials.gov Identifier: NCT00143533 - Recruiting
Neoplasm; Diarrhea
- Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma
ClinicalTrials.gov Identifier: NCT00002988 - Active, not recruiting
recurrent adult brain tumor
- Irinotecan Study For Cervical Cancer
ClinicalTrials.gov Identifier: NCT00136955 - Recruiting
Cervix Neoplasms
- Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Metastatic or Inoperable Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (Cancer)
ClinicalTrials.gov Identifier: NCT00084617 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Phase III Study of Irinotecan and Cetuximab vs Irinotecan as Second-Line Treatment in Patients with Metastatic, EGFR-Positive Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00063141 - Active, not recruiting
Colorectal Cancer
- Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors
ClinicalTrials.gov Identifier: NCT00084877 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors
ClinicalTrials.gov Identifier: NCT00031681 - Recruiting
Cancer
- Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00112892 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00010036 - Active, not recruiting
adult glioblastoma multiforme
- Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00020748 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer
ClinicalTrials.gov Identifier: NCT00002939 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00006485 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00024141 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Irinotecan in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00004051 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00054288 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
ClinicalTrials.gov Identifier: NCT00003276 - Active, not recruiting
recurrent gallbladder cancer; unresectable gallbladder cancer
- Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
ClinicalTrials.gov Identifier: NCT00024284 - Active, not recruiting
unspecified childhood solid tumor, protocol specific
- Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00079352 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00003710 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors
ClinicalTrials.gov Identifier: NCT00003109 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
ClinicalTrials.gov Identifier: NCT00091312 - Active, not recruiting
stage II colon cancer; adenocarcinoma of the colon
- Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
ClinicalTrials.gov Identifier: NCT00074321 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00004923 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00083148 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00047242 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
ClinicalTrials.gov Identifier: NCT00030563 - Active, not recruiting
Colon Cancer; liver metastases; Rectal Cancer
- ZD1839 and Oral Irinotecan in Treating Young Patients with Refractory Solid Tumors
ClinicalTrials.gov Identifier: NCT00132158 - Recruiting
Glioblastoma; Rhabdomyosarcomas; Neuroblastoma; Osteosarcoma
- Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
ClinicalTrials.gov Identifier: NCT00004919 - Active, not recruiting
unspecified childhood solid tumor, protocol specific; Drug Toxicity
- Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00075738 - Active, not recruiting
stage IV esophageal cancer; recurrent esophageal cancer
- Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00099125 - Active, not recruiting
adult giant cell glioblastoma; adult gliosarcoma; adult glioblastoma
- Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer
ClinicalTrials.gov Identifier: NCT00005979 - Active, not recruiting
stage III colon cancer; adenocarcinoma of the colon
- Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
ClinicalTrials.gov Identifier: NCT00093353 - Active, not recruiting
Diarrhea; Drug Toxicity; disseminated neuroblastoma; recurrent neuroblastoma
- Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00004095 - Active, not recruiting
Bladder Cancer; Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer
- Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
ClinicalTrials.gov Identifier: NCT00066612 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
ClinicalTrials.gov Identifier: NCT00397904 - Recruiting
Esophageal Cancer; Gastric Cancer
- Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00104793 - Active, not recruiting
extensive stage small cell lung cancer
- Bortezomib With or Without Irinotecan in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00103259 - Recruiting
Head and Neck Cancer
- Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00079118 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Irinotecan and Cetuximab in Treating Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00275041 - Active, not recruiting
Recurrent Breast Cancer; Stage IV Breast Cancer; Male Breast Cancer
- Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer
ClinicalTrials.gov Identifier: NCT00066391 - Active, not recruiting
penile squamous cell carcinoma; stage III penile cancer; stage IV penile cancer
- Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy
ClinicalTrials.gov Identifier: NCT00039468 - Active, not recruiting
adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma
- Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
ClinicalTrials.gov Identifier: NCT00507091 - Active, not recruiting
Metastatic; Colorectal; Adenocarcinoma
- Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00045162 - Active, not recruiting
extensive stage small cell lung cancer
- Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00027612 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
ClinicalTrials.gov Identifier: NCT00249977 - Active, not recruiting
Solid Tumors; Cancer
- Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00089102 - Active, not recruiting
recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
- Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma
ClinicalTrials.gov Identifier: NCT00006025 - Active, not recruiting
adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
- Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC
ClinicalTrials.gov Identifier: NCT00319800 - Active, not recruiting
Non-Small Cell Lung Cancer
- Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00042939 - Active, not recruiting
adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00080951 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
- Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
ClinicalTrials.gov Identifier: NCT00003427 - Active, not recruiting
Pancreatic Cancer; Colon Cancer; Gastric Cancer; Rectal Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer
- Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
ClinicalTrials.gov Identifier: NCT00089128 - Active, not recruiting
transitional cell carcinoma of the bladder; recurrent bladder cancer; stage III bladder cancer; stage IV bladder cancer
- Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas
ClinicalTrials.gov Identifier: NCT00268359 - Active, not recruiting
Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Adult Glioblastoma; Adult Gliosarcoma; Recurrent Adult Brain Tumor; ...
- Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer
ClinicalTrials.gov Identifier: NCT00100828 - Recruiting
medullary thyroid cancer; recurrent thyroid cancer
- Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
ClinicalTrials.gov Identifier: NCT00066781 - Active, not recruiting
adenocarcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; squamous cell carcinoma of unknown primary; ...
- MRI in Patients Receiving Bevacizumab and Irinotecan for Recurrent Malignant Glioma
ClinicalTrials.gov Identifier: NCT00352521 - Active, not recruiting
Brain and Central Nervous System Tumors
- Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00084604 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
- Irinotecan and Capecitabine in Treating Patients With Solid Tumors
ClinicalTrials.gov Identifier: NCT00003867 - Active, not recruiting
Pancreatic Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer; Colon Cancer; Rectal Cancer; Breast Cancer
- Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00072527 - Active, not recruiting
limited stage small cell lung cancer
- Irinotecan in Treating Patients With Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00003843 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
- Neoadjuvant Irinotecan and Cisplatin Followed By Surgical Resection in Treating Patients With Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00062374 - Active, not recruiting
adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
- Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
ClinicalTrials.gov Identifier: NCT00004068 - Active, not recruiting
high-grade childhood cerebral astrocytoma; untreated childhood brain stem glioma; untreated childhood cerebellar astrocytoma; ...
- Cisplatin, Irinotecan, and Bevacizumab in Treating Patients with Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00118235 - Active, not recruiting
extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
- Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
ClinicalTrials.gov Identifier: NCT00004005 - Active, not recruiting
adult solid tumor; carcinoma of unknown primary; childhood solid tumor; Colon Cancer; Rectal Cancer
- Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00026273 - Active, not recruiting
adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; adenocarcinoma of the colon
- Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00016952 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
- Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00012389 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
- Erlotinib and Irinotecan in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00045201 - Recruiting
unspecified adult solid tumor, protocol specific
- Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00004924 - Active, not recruiting
stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00075595 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
- Topotecan for Irinotecan-Refractory SCLC
ClinicalTrials.gov Identifier: NCT00502762 - Active, not recruiting
Lung Cancer; Refractory to Chemotherapy
- Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00284817 - Active, not recruiting
Cancer
- Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
ClinicalTrials.gov Identifier: NCT00320918 - Active, not recruiting
Cholangiocarcinoma
- A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
ClinicalTrials.gov Identifier: NCT00345163 - Active, not recruiting
Glioblastoma
- Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer
ClinicalTrials.gov Identifier: NCT00506623 - Active, not recruiting
Rectal Neoplasm; Neoadjuvant Therapy
- Irinotecan in Treating Patients With Recurrent Glioma
ClinicalTrials.gov Identifier: NCT00003134 - Active, not recruiting
Adult Oligodendroglioma; recurrent adult brain tumor; adult brain stem glioma; Mixed Gliomas; adult infiltrating astrocytoma
- A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy
ClinicalTrials.gov Identifier: NCT00506207 - Active, not recruiting
Colorectal Neoplasm; Gastric Neoplasm; Secondary
- Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
ClinicalTrials.gov Identifier: NCT00314353 - Active, not recruiting
Colorectal Neoplasms
- Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
Colorectal Neoplasms
- Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00053833 - Active, not recruiting
recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; ...
- Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00003950 - Active, not recruiting
recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
- A Study of 1018 ISS Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00403052 - Active, not recruiting
Colorectal Neoplasms
- Trastuzumab and Irinotecan in Patients with Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00145821 - Recruiting
Advanced Breast Cancer
- Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00012363 - Active, not recruiting
stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
- Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00132054 - Active, not recruiting
extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
- Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00003225 - Active, not recruiting
recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
- Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
ClinicalTrials.gov Identifier: NCT00006269 - Active, not recruiting
recurrent colon cancer; Diarrhea; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
- Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum
ClinicalTrials.gov Identifier: NCT00077233 - Active, not recruiting
adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; recurrent rectal cancer; stage IV colon cancer; ...
- Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00134069 - Active, not recruiting
recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer
- Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00006037 - Active, not recruiting
recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
- Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00004885 - Active, not recruiting
recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; Quality of Life; ...
- Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer
ClinicalTrials.gov Identifier: NCT00165464 - Active, not recruiting
Esophageal Cancer; Gastric Cancer; GE Junction Cancer
- Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00193375 - Active, not recruiting
Lung Cancer
- Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00217711 - Active, not recruiting
Colorectal Cancer
- Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
ClinicalTrials.gov Identifier: NCT00220168 - Active, not recruiting
Upper Gastrointestinal Tumours
- Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00248482 - Active, not recruiting
Lung Cancer
Resources
- Camptosar (Drug Digest)
- Irinotecan (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
